ENSIGN GROUP INC (ENSG)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ENSG
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ENSG | Director | 61 | ["senior healthcare executive", "Chief Executive Officer of Herbalife Nutrition Inc.", "Chairman of Herbalife Nutrition Inc.", "Chief Health and Nutrition Officer at Herbalife", "Co-President of Herbalife", "independent consultant to health-related companies", "board member of Magellan Health, Inc.", "Senior Vice President and President of Health and Wellness at Walmart U.S.", "Assistant Secretary of Health at the U.S. Department of Health and Human Services"] | ["Audit Committee", "Quality Assurance & Compliance", "Nominating and Corporate Governance Committee", "Quality Assurance and Compliance Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Agwunobi has held several positions in both the public and private sector. He assumed the role of Chief Executive Officer in March 2020 and Chairman in April 2020 at Herbalife Nutrition Inc., a multinational multi-level marketing corporation that develops and sells dietary supplements, holding both positions until October 2022. Previously, Dr. Agwunobi served as Chief Health and Nutrition Officer at Herbalife, responsible for training, education, science strategy and product development since 2016. He has also served as Co- President of Herbalife from May 2018 to March 2020. Prior to joining Herbalife, Dr. Agwunobi was an independent consultant, advising a number of privately-held health-related companies, including serving as an advisory board member of Shopko Stores Operating Co., LLC on behalf of the private equity firm Sun Capital Partners. He also served as a member of the board for Magellan Health Inc., a for-profit managed health care company, focused on special populations, complete pharmacy benefits and other specialty areas of healthcare from December 2014 to June 2019. From September 2007 to April 2014, Dr. Agwunobi served as Senior Vice President and President of Health and Wellness for Wal-Mart (NYSE: WMT) in the United States where he grew the business and provided insight and advice on the company s health reform position. From December 2005 to September 2007, he served as the Assistant Secretary of Health for the U.S. Department of Health and Human Services, where he was responsible for disease prevention and health promotion. His responsibilities included the oversight of the Centers for Disease Control, National Institute of Health, the U.S. Food and Drug Administration, the Office of the U.S. Surgeon General, and numerous other public health offices and programs. Dr. Agwunobi currently serves as a director for bluebird bio Inc. (NASDAQ: BLUE), a biotechnology company committed to developing gene therapies for severe genetic diseases, a post that he has held since June 2017. He is also currently serving as a member of the board of the U.S. African Development Foundation and has been serving in that capacity since 2008.